第 卷第 期 华 夏 医 学 34 4 , ∥ ’ Hospital of Lianjiang Lianjiang 524400 China , , Abstract Objective: To investigate the clinical effects of montelukast sodium combined with budesonide formoterol(symbicort)in the treatment of patients with bronchial asthma(BA)and its influence on the lung function and level of inflammation. Methods: A total of 86 BA patients were randomized into the control group(43 cases)and observation group(43 cases). The control group were treated with Symbicort, while the observation group were treated with montelukast sodium. The clinical efficacy, pulmonary function indexes, inflammatory factor levels and adverse reactions were compared between the two groups. Results: The total effective rate of treatment in the observation group was higher than that in the control group P ( <);after treatment, FVC, PEFR and FEV1 of the observation group were higher than those of the P control group, which were of statistical differences( <); while TNF-α, IL-6 and IL-8 in the observation group were lower than those of the control group, which were of sta
